Legal Cannabis Companies are Looking to Grow
FinancialBuzz.com News Commentary
NEW YORK, October 26, 2017 /PRNewswire/ --
According to a report by Forbes, a new research by Brightfield Group projects that the hemp-derived cannabidiol (CBD) will be billion-dollar market in just three years. The market is estimated to grow at a 55% compound annual growth rate over the next five years. The research indicates that 64.5% of the total revenue in the market come from the online channels, followed by 17.8% at smoke shops. Dispensaries also played a major role, with 9% of the sales. Hemp CBD is sold in all 50 states. "One of the most surprising things we found during this research was how many companies are currently operating in the space, and how few of them are generating significant revenue," said Bethany Gomez, the Director of Research at Brightfield Group, according to an article by Forbes. "Essentially everyone is trying to do hemp, but only a handful are doing it well." Global Payout, Inc. (OTC: GOHE), SinglePoint (OTC: SING), Marijuana Company of America (OTC: MCOA), MassRoots, Inc. (OTC: MSRT), AXIM Biotechnologies, Inc. (OTC: AXIM)
Growth of the medical cannabis market is expected to accelerate as the products become more popular treatments for various medical applications such as chronic pain, post-traumatic stress disorder (PTSD), sleep disorders, anxiety, nerve pain and others. "The United States constitutes 35% of the global pharmaceutical market, the largest market in the world, and a major driver of the U.S. economy. It is one of many industries that will be impacted by the growth of the legal cannabis market and we are already starting to see that trend in legal medical states where use of key prescription drugs is down by 11%. If cannabis were to be adopted nationally, we would begin to see a trend of patients turning to medical cannabis as a substitute or complement to pharmaceuticals," said Giadha Aguirre De Carcer, CEO and Founder, New Frontier Data.
Global Payout, Inc. (OTC: GOHE) announced today that, "its majority owned subsidiary, MoneyTrac Technology, Inc. ("MTRAC", the "Company") is currently in the process of ramping-up sales and marketing efforts within Los Angeles County for its newly acquired brand, PotSaver. PotSaver will be releasing its premier Los Angeles publication on January 1st 2017 to coincide with the legalization of recreational use of cannabis in the most populous state in the country, California.
In the last year, PotSaver, a revenue producing, community periodical and online advertising platform that provides listings on discounted cannabis-related products for local dispensaries and shops has established a significant presence within the San Diego County cannabis community behind the efforts of its founder, Aaron Adler. In having been acquired by MTRAC in September 2017, PotSaver has been afforded the foundational and financial support needed to engage in a full-fledged sales and marketing campaign to expand the brand's footprint into both the Orange and Los Angeles County markets.
In recent weeks, MTRAC management has been working diligently to form a powerhouse inside and outside sales and marketing team that will work in collaboration to facilitate the successful launch of PotSaver's publication in Los Angeles. Mr. Adler will supervise this team and expand PotSaver's reach by executing subscription agreements with many of the top dispensaries, service and product providers throughout this newly available market, one that is expected to grow exponentially at the turn of the new year."
SinglePoint (OTC: SING) specializes in acquisitions of small to mid-sized companies, with an emphasis in new technologies. Recently, the company has entered into a Letter of Intent with AppSwarm to conduct a joint roll-out of mobile applications specifically geared to the cannabis industry. The applications will be branded and marketed under SinglePoint's SingleSeed subsidiary, while AppSwarm will provide the necessary technical support and app development. SinglePoint and AppSwarm plan to launch the first application within 90 days of the LOI, as well as release an additional two applications every 90 days thereafter. The first application will provide a base for additional applications, and will be a service-based application for the business-to-business (B2B) and business-to-consumer (B2C) markets.
Marijuana Company of America (OTC: MCOA) offers investors the opportunity to be on the forefront of innovation in the legal cannabis and industrial hemp industries. On October 10, 2017, the company announce that they have jointly entered into a letter of intent with Space Cowboys, Inc. for the purposes of forming a joint venture. Space Cowboys is an existing fully licensed and compliant hemp derived cannabinoid producer in Colorado. Pursuant to the terms of the letter of intent and subject to the Companies obtaining sufficient financing, the Companies will invest US$2.5 Million in exchange for a 25% equity interest in Space Cowboys. The investment funds will be used to expand Space Cowboys' cultivation operation.
MassRoots, Inc. (OTCQB: MSRT) is one of the leading technology platforms for the regulated cannabis industry. Powered by more than one million registered users, the Company's mobile apps empower consumers to make educated cannabis purchasing decisions through community-driven reviews. Recently, the company announced the release of its new Dispensary Finder service with 6,000 entries that catalogue all medical, recreational and delivery-based dispensaries in nine states. MassRoots launched its Dispensary Finder service together with Sweet Leaf, a leading medical and recreational dispensary chain with over 20 locations in Colorado, California and Oregon with headquarters in Denver, as Dispensary Finder's first promoted customer.
AXIM Biotechnologies, Inc. (OTCQB: AXIM) focuses on the research, development and production of cannabis-based pharmaceutical, nutraceutical and cosmetic products. On October 05, 2017, the company announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. Application Serial Number 14/982,610, a patent that claims the use of an ophthalmic solution comprising cannabinoids for the treatment of glaucoma and symptomatic relief of conjunctival inflammation. AXIM® Biotech announced on March 21, 2017 that it retained the services of Ora®, Inc., a global Contract Research Organization, to perform the company's product development (based on AXIM's IP) in glaucoma and dry eye syndrome utilizing cannabinoid-based therapeutics through its AX-1603 and AX-1606 clinical programs.
Subscribe Now! Watch us report from NYSE https://www.youtube.com/FinancialBuzzMedia
Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz
Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz
Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/
About FinancialBuzz.com
FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.
Please Note: FinancialBuzz.com is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on http://www.FinancialBuzz.com (the 'Site') is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content), FinancialBuzz.com, a financial news media and marketing firm enters into media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies. Financialbuzz.com has not been compensated directly by any of the companies mentioned here in this editorial. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. FinancialBuzz.com receives fees for producing and presenting high quality and sophisticated content on FinancialBuzz.com along with other financial news PR media services. FinancialBuzz.com does not offer any personal opinions, recommendations or bias commentary as we purely incorporate public market information along with financial and corporate news. FinancialBuzz.com only aggregates or regurgitates financial or corporate news through our unique financial newswire and media platform. For this release, FinancialBuzz.com has been compensated four thsouand dollars for financial news dissemination and pr services by a non-affiliate third party for global payout, inc. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this editorial or site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. FinancialBuzz.com will always disclose any compensation in securities or cash payments for financial news PR advertising. FinancialBuzz.com does not undertake to update any of the information on the editorial or Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security. FinancialBuzz.com, members and affiliates are not responsible for any gains or losses that result from the opinions expressed on this editorial or Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. FinancialBuzz.com. By accessing this editorial and website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by FinancialBuzz.com constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by FinancialBuzz.com. Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use. Please visit: http://www.financialbuzz.com .
For further information:
Media Contact: [email protected] , +1-877-601-1879
URL: http://www.FinancialBuzz.com
SOURCE FinancialBuzz.com
Share this article